My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Board of Ushdev International discussed classification of its loan account as NPA by banks
Nov 23,2016

Ushdev International announced that the Board Meeting of the Company was held on 22 November 2016. The Board of Directors at the Board Meeting of the Company discussed that few Banks have declared the loan account of the Company as Non Performing Asset and India Ratings and Research Private has revised the rating of the Company. The Board discussed in length and the Company is working on a suitable solution.

Powered by Capital Market - Live News

Board of Ushdev International discuss classification of its loan account as NPA by banks
Nov 23,2016

Ushdev International announced that the Board Meeting of the Company was held on 22 November 2016. The Board of Directors at the Board Meeting of the Company discussed that few Banks have declared the loan account of the Company as Non Performing Asset and India Ratings and Research Private has revised the rating of the Company. The Board discussed in length and the Company is working on a suitable solution.

Powered by Capital Market - Live News

Intellect Design Arena gets assigned credit ratigns
Nov 23,2016

Intellect Design Arena announced that CRISIL, vide its letter dated 22 November 2016, has assigned credit rating of :

a) BBB+/ Stable rating for Long Term Loans, and

b) CRISIL A2 for Short Term Loans.

Powered by Capital Market - Live News

A2Z Infra Engineering jumps as subsidiary to settle various debts
Nov 23,2016

Meanwhile, the BSE Sensex was down 48.70 points, or 0.19%, to 25,912.08.

On BSE, so far 5.83 lakh shares were traded in the counter, compared with average daily volume of 2.50 lakh shares in the past one quarter. The stock hit a high of Rs 41.40 and a low of Rs 38.60 so far during the day. The stock hit a 52-week high of Rs 51.65 on 1 November 2016. The stock hit a 52-week low of Rs 16.50 on 12 February 2016. The stock had outperformed the market over the past 30 days till 22 November 2016, falling 2.82% compared with the 7.87% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 2.82% as against Sensexs 7.48% decline.

The small-cap company has equity capital of Rs 129.62 crore. Face value per share is Rs 10.

A2Z Infra Engineering informed that its subsidiary, A2Z Green Waste Management (A2Z Green), has on 19 November 2016, agreed to a framework with one of its lenders for a settlement of its various debt obligation aggregating to Rs 416.18 crore.

The settlement may include the transfer of two projects of A2Z Green namely: a 500 tonne per day (TPD) of processing and disposal unit for the purposes of municipal solid waste management at Indore city; and a 1500 TPD of P&D unit, collection & transportation facility of municipal solid waste along with 15 megawatts (MW) power plant, located in Kanpur city.

The settlement would be subject to execution of definitive agreement(s) and further subject to various requisite approval(s) of its stake holders including shareholders and lenders as may be required.

Shares of A2Z Infra Engineering surged 12.80% to Rs 37.90 yesterday, 22 November 2016, after the company said that a contract has been awarded to the company by Chhattisgarh State Power Transmission Company for construction of 132 kilovolt S/S Bijapur and associated EHV Line on turnkey basis. The aggregate value of the contract is Rs 41.33 crore. The announcement was made during market hours yesterday, 22 November 2016.

The stock has risen 19.35% in two trading sessions from its close of Rs 33.60 on Monday, 21 November 2016.

A2Z Infra Engineering reported a net loss of Rs 18.75 crore in Q1 June 2016, lower than net loss of Rs 34.21 crore in Q1 June 2015. Net sales surged 148.5% to Rs 202.70 crore in Q1 June 2016 over Q1 June 2015.

A2Z Infra Engineering (formerly known as A2Z Maintenance & Engineering Services) is a fast growing, fully integrated electrical business group (EBG) in India catering to the needs of domestic and international power sector clients in building distribution and transmission infrastructure.

Powered by Capital Market - Live News

Yes Bank commits to NHAIs Adopt Green Highway program
Nov 23,2016

Yes Bank has become the first private sector player into a Corporate Social Responsibility commitment with the National Highways Authority under its Adopt Green Highway program. Through this partnership, Yes Bank is committed to developing green corridors along Mumbai-Nashik-Pimpalgaon Highway.

Powered by Capital Market - Live News

Board of Prestige Estates Projects to consider September quarter and half year results
Nov 23,2016

Prestige Estates Projects announced that a Meeting of the Board of Directors of the Company is scheduled to be held on 07 December 2016, inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended 30 September 2016.

Powered by Capital Market - Live News

SREI Infrastructure Finance appoints CEO
Nov 23,2016

SREI Infrastructure Finance announced the appointment of Sameer Sawhney as Chief Executive Officer, effective 05 November 2016.

Powered by Capital Market - Live News

JBF Industries weaves strong gains after stellar Q2 results
Nov 23,2016

The result was announced after market hours yesterday, 22 November 2016.

Meanwhile, the S&P BSE Sensex was up 2.79 points, or 0.01%, to 25,963.57

On BSE, so far 16,000 shares were traded in the counter, compared with average daily volume of 29,882 shares in the past one quarter. The stock hit a high of Rs 211.40 and a low of Rs 199 so far during the day. The stock hit a 52-week high of Rs 260.10 on 18 October 2016. The stock hit a 52-week low of Rs 150.10 on 29 February 2016. The stock had underperformed the market over the past 30 days till 22 November 2016, sliding 20.22% compared with the 7.87% decline in the Sensex. The scrip, however, outperformed the market in past one quarter, falling 6.56% as against Sensexs 7.48% decline.

The small-cap company has an equity capital of Rs 81.87 crore. Face value per share is Rs 10.

JBF Industries produces polyester chips for textiles, films and bottles and partially oriented yarn.

Powered by Capital Market - Live News

Board of Reliance Chemotex Industries to approve change in CFO
Nov 23,2016

Reliance Chemotex Industries announced that a Meeting of Board of Directors of the Company will be held on 30 November 2016 to take note on resignation of Ravindra Kala, Chief Financial Officer and to consider and appoint Kiran Firodiya, as Chief Financial Officer (KMP).

Powered by Capital Market - Live News

Tentiwala Metal Products to announce September half year results
Nov 23,2016

Tentiwala Metal Products announced that the meeting of Board of Directors will be held on 30 November 2016, to consider, approve and to take on record Un-Audited Financial Results for the half-year ended on 30 September 2016.

Powered by Capital Market - Live News

EPC Industrie allots equity shares
Nov 23,2016

EPC Industrie announced that the Nomination and Remuneration Committee of Directors on 22 November 2016 has allotted 11,877 Equity Shares of Rs. 10 each respectively to the Employees of the Company who have exercised their Stock Options under the Companys Employee Stock Option Scheme, 2014.

Post allotment, the Paid up capital of the Company stands increased to 2,76,70,349 Shares of Rs. 10 each aggregating to Rs. 27,67,03,490/- (Rupees Twenty Seven Crores Sixty Seven lacs Three Thousand Four Hundred Ninety only).

Further, the Committee has also granted new 1,33,432 Stock Options to employees.

Powered by Capital Market - Live News

Bhagyanagar India intimates of High Court sanction for scheme of arrangement
Nov 23,2016

Bhagyanagar India announced that the Honble High Court of Hyderabad has sanctioned the scheme of arrangement on 21 November 2016 between Bhagyanagar India (demerged company) and Surana Telecom and Power (1st results company) and Bhagyanagar Properties (2nd resulting company) and their respectively shareholders and creditors.

Powered by Capital Market - Live News

Sun Pharmaceutical Industries announces resignation of CFO
Nov 23,2016

Sun Pharmaceutical Industries announced that the Company have received a letter intimating to the Company from the Companys Chief Financial Officer (CFO), Uday Baldota that he would be tendering his resignation as the CFO of Sun Pharmaceutical Industries to be effective with effect from in and around April, 2017 due to his shifting to United States of America in and around April, 2017 to look after the business of Taro Pharmaceutical Industries, a subsidiary of Sun Pharmaceutical Industries as its Chief Executive Officer.

Powered by Capital Market - Live News

Sun Pharma gains after acquisition in Russia
Nov 23,2016

The announcement was made before trading hours today, 23 November 2016.

Meanwhile, the BSE Sensex was up 4.56 points, or 0.02%, to 25,965.34.

On BSE, so far 48,000 shares were traded in the counter, compared with average daily volume of 3.49 lakh shares in the past one quarter. The stock hit a high of Rs 696.65 and a low of Rs 691.55 so far during the day. The stock hit a 52-week high of Rs 898 on 23 February 2016. The stock hit a 52-week low of Rs 572.40 on 9 November 2016. The stock had outperformed the market over the past 30 days till 22 November 2016, falling 7.68% compared with the 7.87% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 10.50% as against Sensexs 7.48% decline.

The large-cap company has equity capital of Rs 240.68 crore. Face value per share is Re 1.

Sun Pharmaceutical Industries (Sun Pharma) announced the execution of definitive agreements by its wholly owned subsidiary, for the acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical company engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region. The equity consideration for the 85.1% stake is $24 million. Sun Pharma would also assume a debt of approximately $36 million as part of this transaction. Biosintez is a Russian pharmaceutical company focusing on the hospital segment with annual revenues of approximately $52 million for 2015. It has a manufacturing facility in Penza region with capabilities to manufacture a wide variety of dosage forms including pharmaceuticals for injections, blood substitutes, blood preservatives, ampoules, tablets, ointment, creams, gels, suppositories, active pharmaceutical ingredients (APIs), etc.

The transaction, expected to be completed by end of 2016, is subject to approval of the Russian Federal AntiMonopoly Service and other closing conditions. As per IMS (MAT September 2016), the Russian pharmaceutical market recorded sales of approximately $10 billion. The market recorded a growth of 7.4% in local currency terms as per IMS.

In a separate announcement after market hours yesterday, 22 November 2016, Sun Pharma said it received a letter from the Chief Financial Officer (CFO), Uday Baldota that he would be tendering his resignation as the CFO of Sun Pharmaceutical Industries to be effective with effect from in and around April 2017 due to his shifting to United States of America in and around April 2017 to look after the business of Taro Pharmaceutical Industries, a subsidiary of Sun Pharmaceutical Industries as its Chief Executive Officer.

On a consolidated basis, Sun Pharmaceutical Industries net profit surged 117.25% to Rs 2235.14 crore on 13.21% rise in net sales to Rs 7764.03 crore in Q2 September 2016 over Q2 September 2015.

Sun Pharmaceutical Industries is the worlds fifth largest specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Surana Telecom and Power gets High Court approval for scheme of arrangement
Nov 23,2016

Surana Telecom and Power announced that the Honble High Court of Hyderabad has sanctioned the scheme of arrangement between Bhagyanagar India (demerged company) and Surana Telecom and Power (1st results company) and Bhagyanagar Properties (2nd resulting company) and their respectively shareholders and creditors.

Powered by Capital Market - Live News